Related Experiment Video
Updated: Sep 15, 2025

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
Non-canonical activating roles of RCoR2 sustain transcription in adrenergic neuroblastoma
Sara Aloisi1, Martina Santulli1, Marco Russo2
1Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
Abstract:
CoREST complexes (LSD1, HDAC1/2, and RCoR1/2/3) are pivotal in neurodevelopment and have long been recognized as transcriptional repressors across various cancers. However, distinct roles of RCoR factors remain underexplored. Here, we unveil non-canonical functions of RCoR2 in MYCN-amplified neuroblastoma (NB), underscoring its unique significance compared to its paralogs. This insight shifts the paradigm, highlighting RCoR2 as a key determinant of the NB chromatin landscape. Our findings demonstrate that RCoR2 is a super-enhancer-driven gene, which, unlike RCoR1, acts as a positive regulator of gene expression as a partner of the adrenergic NB core regulatory circuitry (CRC). We propose a model in which RCoR2 facilitates interactions between CRC-bound enhancers and their associated transcription start sites, thereby sustaining the expression of genes critical for NB cell survival. Thus, we identify RCoR2 as a critical vulnerability in high-risk NBs and a promising target for cancer therapeutics.
Insights
The study reveals RCoR2, a component of CoREST complexes, plays a novel positive role in gene regulation in neuroblastoma (NB). This finding identifies RCoR2 as a potential therapeutic target for high-risk NB cancers.
Area of Science:
- Epigenetics and Gene Regulation
- Cancer Biology
- Neuro-oncology
Background:
- CoREST complexes, including LSD1, HDAC1/2, and RCoR1/2/3, are crucial for neurodevelopment and cancer.
- The specific roles of RCoR paralogs, particularly RCoR2, in cancer remain largely uncharacterized.
Purpose of the Study:
- To investigate the non-canonical functions of RCoR2 in MYCN-amplified neuroblastoma (NB).
- To elucidate the role of RCoR2 in regulating the NB chromatin landscape and gene expression.
Main Methods:
- Analysis of RCoR2's role in MYCN-amplified neuroblastoma.
- Investigating RCoR2 as a super-enhancer-driven gene.
- Examining RCoR2's interaction with the core regulatory circuitry (CRC) in NB.
Main Results:
- RCoR2 exhibits non-canonical functions in MYCN-amplified neuroblastoma, distinct from its paralogs.
- RCoR2 is a super-enhancer-driven gene that positively regulates gene expression.
- RCoR2 acts as a partner of the adrenergic NB core regulatory circuitry (CRC), facilitating enhancer-promoter interactions.
Conclusions:
- RCoR2 is a key determinant of the NB chromatin landscape and a positive regulator of gene expression.
- RCoR2 sustains the expression of genes vital for neuroblastoma cell survival.
- RCoR2 represents a critical vulnerability and a promising therapeutic target in high-risk neuroblastomas.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Co-activators and Co-repressors
RNA Polymerase II Accessory Proteins
Master Transcription Regulators
MAPK Signaling Cascades
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

